nice tirzepatide obesity Lilly wins endorsement for in obesity—with a catch VisualAbstract: Once-weekly tirzepatide significantly improves

If libido loss, discomfort, or emotional distress persists for several weeks, speak with a clinician

Tirzepatide is a synthetic peptide based on human GIP that activates both GIP and GLP-1 receptors, whilst exendin-4 is a naturally occurring peptide that acts only on GLP-1 receptors

Dosing & Reconstitution Guide Educational guide for reconstitution and daily dosing Standard / Gradual Approach (3 mL = ~1.67 mg/mL) Frequency: Inject once daily subcutaneously

Surgery is largely permanent

Continued Treatment with Tirzepatide for Maintenance of Weight Reduction in Adults with Obesity: The SURMOUNT-4 Randomized Clinical Trial. JAMA 331(1):3848

It is important to understand that these medications are not standalone solutions